Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Cramer

Showing results (101-110 of 233) with videos related to

Pageof 24
Sort By:
JAMA|April 3, 2002
Osteopontin as a potential diagnostic biomarker for ovarian cancerJae-Hoon Kim, Steven J Skates, Toshimitsu Uede, et al.
American Journal of Epidemiology|October 9, 2002
Association of galactose-1-phosphate uridyltransferase activity and N314D genotype with the risk of ovarian cancerMarc T Goodman, Anna H Wu, Ko-Hui Tung, et al.
Cancer Causes & Control : CCC|June 19, 2010
Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma riskGalina Lurie, Kathryn L Terry, Lynne R Wilkens, et al.
Gynecologic Oncology|September 7, 2010
MTHFR polymorphisms in relation to ovarian cancer riskKathryn L Terry, Shelley S Tworoger, Ellen L Goode, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urineBin Ye, Steven Skates, Samuel C Mok, et al.
Gynecologic Oncology|August 24, 2024
Serum miRNA improves the accuracy of a multivariate index assay for triage of an adnexal massJames W Webber, Laura Wollborn, Sudhanshu Mishra, et al.
Proteomics. Clinical Applications|April 29, 2016
Proteomic mapping of p53 immunogenicity in pancreatic, ovarian, and breast cancersBenjamin A Katchman, Rodrigo Barderas, Rizwan Alam, et al.
Environmental Health Perspectives|February 25, 2011
Serum concentrations of polychlorinated biphenyls in relation to in vitro fertilization outcomesJohn D Meeker, Arnab Maity, Stacey A Missmer, et al.
International Journal of Cancer|February 1, 2013
Ovarian cancer risk factors by tumor dominance, a surrogate for cell of originJoanne Kotsopoulos, Kathryn L Terry, Elizabeth M Poole, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancerJohn O Schorge, Richard D Drake, Hang Lee, et al.
Pageof 24

Showing results (101-110 of 233) with videos related to

Sort By:
Pageof 24
JAMA|April 3, 2002
Osteopontin as a potential diagnostic biomarker for ovarian cancerJae-Hoon Kim, Steven J Skates, Toshimitsu Uede, et al.
American Journal of Epidemiology|October 9, 2002
Association of galactose-1-phosphate uridyltransferase activity and N314D genotype with the risk of ovarian cancerMarc T Goodman, Anna H Wu, Ko-Hui Tung, et al.
Cancer Causes & Control : CCC|June 19, 2010
Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma riskGalina Lurie, Kathryn L Terry, Lynne R Wilkens, et al.
Gynecologic Oncology|September 7, 2010
MTHFR polymorphisms in relation to ovarian cancer riskKathryn L Terry, Shelley S Tworoger, Ellen L Goode, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urineBin Ye, Steven Skates, Samuel C Mok, et al.
Gynecologic Oncology|August 24, 2024
Serum miRNA improves the accuracy of a multivariate index assay for triage of an adnexal massJames W Webber, Laura Wollborn, Sudhanshu Mishra, et al.
Proteomics. Clinical Applications|April 29, 2016
Proteomic mapping of p53 immunogenicity in pancreatic, ovarian, and breast cancersBenjamin A Katchman, Rodrigo Barderas, Rizwan Alam, et al.
Environmental Health Perspectives|February 25, 2011
Serum concentrations of polychlorinated biphenyls in relation to in vitro fertilization outcomesJohn D Meeker, Arnab Maity, Stacey A Missmer, et al.
International Journal of Cancer|February 1, 2013
Ovarian cancer risk factors by tumor dominance, a surrogate for cell of originJoanne Kotsopoulos, Kathryn L Terry, Elizabeth M Poole, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancerJohn O Schorge, Richard D Drake, Hang Lee, et al.
Pageof 24